Patients for Affordable Drugs Now

Last updated

Patients For Affordable Drugs Now is a patient advocacy and lobbying organisation based in Washington, D.C., which focuses on policies to lower drug prices in the United States. It was founded by David Mitchell (who suffers from multiple myeloma), and has Merith Basey as its Executive Director since 2022.

It is financed by the Action Now Initiative (ANI) which is funded by the Laura and John Arnold Foundation. [1] It is bipartisan and does not accept funding from any organizations that profit from development or distribution of prescription drugs. [2]

Patients For Affordable Drugs Now has a separate political action arm called Patients for Affordable Drugs Action. [3] It spent about $10 million to highlight drug prices as an issue in the 2018 United States elections. [4]

In March 2019 Mitchell welcomed the suggestion that drug companies should be made to disclose the prices of their products in television commercials but said “We have not seen any evidence that it will lower drug prices." [5]

When Eli Lilly and Company announced a halving of the price of insulin lispro Wakana denounced the move as a "token PR play". [6]

It supports the proposal for a Prescription Drug Affordability Board as is being considered in Maryland [7] and similar proposals made in Washington. [8]

In 2022 it pointed out that the price of Humalog, Eli Lilly's insulin had increased from $20 in 1996 to $275. [9]

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical Research and Manufacturers of America</span> Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, D.C.

<span class="mw-page-title-main">Generic drug</span> Pharmaceutical equivalent to a brand-name product

A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance compared to their performance at the time when they were patented drugs. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.

Prescription drug list prices in the United States continually are among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to patients using such medications with the goal of curing and/or preventing disease. Pharmaceutical companies may deal in "generic" medications and medical devices without the involvement of intellectual property, in "brand" materials specifically tied to a given company's history, or in both within different contexts. The industry's various subdivisions are all subject to a variety of laws and regulations that govern entire financial processes including the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020, in total, and this showed a compound annual growth rate (CAGR) of 1.8% given the results of recent events.

<span class="mw-page-title-main">Eli Lilly and Company</span> American pharmaceutical company

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

<span class="mw-page-title-main">Novo Nordisk</span> Danish pharmaceutical company

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.

<span class="mw-page-title-main">Secobarbital</span> Obsolete sedative-hypnotic

Secobarbital is a short-acting barbiturate derivative drug that was patented in 1934 in the United States. It possesses anaesthetic, anticonvulsant, anxiolytic, sedative, and hypnotic properties. In the United Kingdom, it was known as quinalbarbitone. It is the most frequently used drug in physician-assisted suicide within the United States. Secobarbital is considered to be an obsolete sedative-hypnotic, and as a result, it has largely been replaced by the benzodiazepine family. Seconal was widely abused, known on the street as "red devils" or "reds". Among the barbiturates, secobarbital carries a particularly high risk of abuse and addiction, largely responsible for its falling out of use.

<span class="mw-page-title-main">Alex Azar</span> American attorney, businessman, lobbyist and pharmaceutical executive (born 1967)

Alex Michael Azar II is an American attorney, businessman, lobbyist, and former pharmaceutical executive who served as the U.S. Secretary of Health and Human Services from 2018 to 2021. Azar was nominated to his post by President Donald Trump on November 13, 2017, and confirmed by the United States Senate on January 24, 2018. He was also chairman of the White House Coronavirus Task Force from its inception in January 2020 to February 2020, when he was replaced by Vice President Mike Pence.

<span class="mw-page-title-main">Inhalable insulin</span> Powdered insulin delivered with an inhaler

Inhalable insulin is a powdered form of insulin, delivered with an inhaler into the lungs where it is absorbed. In general inhaled insulins have been more rapidly absorbed than subcutaneous injected insulin, with faster peak concentration in serum and more rapid metabolism.

Venture philanthropy is a type of impact investment that takes concepts and techniques from venture capital finance and business management and applies them to achieving philanthropic goals. The term was first used in 1969 by John D. Rockefeller III to describe an imaginative and risk-taking approach to philanthropy that may be undertaken by charitable organizations.

<span class="mw-page-title-main">Insulin lispro</span> Rapid-acting insuline analog

Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. It is delivered subcutaneously either by injection or from an insulin pump. Onset of effects typically occurs within 30 minutes and lasts about 5 hours. Often a longer-acting insulin like insulin NPH is also needed.

Medication costs, also known as drug costs are a common health care cost for many people and health care systems. Prescription costs are the costs to the end consumer. Medication costs are influenced by multiple factors such as patents, stakeholder influence, and marketing expenses. A number of countries including Canada, parts of Europe, and Brazil use external reference pricing as a means to compare drug prices and to determine a base price for a particular medication. Other countries use pharmacoeconomics, which looks at the cost/benefit of a product in terms of quality of life, alternative treatments, and cost reduction or avoidance in other parts of the health care system. Structures like the UK's National Institute for Health and Clinical Excellence and to a lesser extent Canada's Common Drug Review evaluate products in this way.

<span class="mw-page-title-main">Martin Shkreli</span> American financial investor and businessman (born 1983)

Martin Shkreli is an American investor and businessman. He was convicted of financial crimes for which he served over six years in federal prison and was fined over 70 million dollars. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

<span class="mw-page-title-main">Dulaglutide</span> Diabetes medication

Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. It is a once-weekly injection.

<span class="mw-page-title-main">Michael Howard (American politician)</span> American politician

Michael 'Mike' Howard is an American politician serving in the Minnesota House of Representatives since 2019. A member of the Minnesota Democratic–Farmer–Labor Party (DFL), Howard represents District 51A in the south-central Twin Cities metropolitan area, which includes the city of Richfield and parts of Minneapolis in Hennepin County.

Health Action International (HAI) is a non-profit organization based in The Netherlands. Established in 1981, HAI works to expand access to essential medicines through research, policy analysis and intervention projects. The organization focuses on snakebite envenoming, access to insulin and developing European policies on medicines. HAI is listed by the World Health Organization (WHO) as an official non-state actor.

<span class="mw-page-title-main">Elijah Cummings Lower Drug Costs Now Act</span> Proposed legislation

The Elijah Cummings Lower Drug Costs Now Act is proposed legislation in the 117th United States Congress. The bill is designed to lower prescription drug costs in the United States. Notably, the law gives the federal government the power to negotiate prescription drug prices. The legislation takes the name of late Maryland Representative Elijah Cummings.

Erin Gilmer was an American disability activist and lawyer. She was known for her work aimed at lowering drug prices and making health care provisions more compassionate.

<span class="mw-page-title-main">Tirzepatide</span> Anti-diabetic and weight loss medication

Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. It is sold under the brand names Mounjaro for diabetes treatment, and Zepbound for weight loss.

<span class="mw-page-title-main">T1International</span> Global diabetes charity

T1International is a not for profit organization that advocates for people with type 1 diabetes. It launched the insulin4all social media campaign and organised two high profile protests outside Ely Lilly and Company headquarters.

References

  1. "Who's P4ADNOW?". Patients For Affordable Drugs Now. Retrieved 2019-04-24.
  2. Lieberman, Trudy. "Maybe the U.S. is finally serious about lowering drug prices". Post-Tribune. Retrieved 2019-04-24.
  3. McCarthy, Tom (2018-10-28). "'Supporting greed over needs': the group taking on big pharma in the midterms". The Guardian. ISSN   0261-3077 . Retrieved 2019-04-24.
  4. "Why is this drug pricing PAC spending millions on long-shot races?". STAT. 2018-10-05. Retrieved 2019-04-24.
  5. "Drug Prices on TV? They May Be Coming". New York Times. 23 March 2019. Retrieved 15 April 2019.
  6. "Drug company announces new version of insulin at half the price". The Hill. 3 April 2019. Retrieved 15 April 2019.
  7. "Maryland drug affordability board 'can be national model', claims group". The PharmaLetter. 29 March 2019. Retrieved 15 April 2019.
  8. "Legal News: New campaign supports drug pricing measures". Tacoma Weekly. 5 April 2019. Retrieved 15 April 2019.
  9. "A Twitter meltdown sheds light on the murky economics of insulin". Marketplace. 14 November 2022. Retrieved 19 November 2022.